We are live on ! Find out more
PRCT icon

Procept Biorobotics
PRCT

58 hedge funds and large institutions have $1.08B invested in Procept Biorobotics in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

48% more capital invested

Capital invested by funds: $732M → $1.08B (+$351M)

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

2.71% more ownership

Funds ownership: 67.7% → 70.42% (+2.7%)

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

3% less funds holding

Funds holding: 60 → 58 (-2)

Holders
58
Holders Change
-2
Holders Change %
-3.33%
% of All Funds
0.91%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
19
Increased
18
Reduced
16
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$58.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$26M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$6.94M
4
DCM
Driehaus Capital Management
Illinois
+$4.33M
5
DI
DUMAC Inc
North Carolina
+$3.98M

Top Sellers

1
Viking Global Investors
Viking Global Investors
Connecticut
-$30.1M
2
DFO
Duquesne Family Office
New York
-$12.8M
3
CI
CPMG Inc
Texas
-$7.32M
4
PC
PointState Capital
New York
-$6.77M
5
Renaissance Technologies
Renaissance Technologies
New York
-$4.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
CI
1
CPMG Inc
Texas
$382M -$7.32M -304,269 -3%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$173M +$26M +1,078,877 +28%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$135M +$58.8M +2,442,421 +174%
Viking Global Investors
4
Viking Global Investors
Connecticut
$128M -$30.1M -1,249,000 -25%
PA
5
Perceptive Advisors
New York
$52.1M +$3.85M +159,999 +12%
DFO
6
Duquesne Family Office
New York
$39.5M -$12.8M -532,394 -32%
JJ
7
Johnson & Johnson
New Jersey
$35.6M – – –
Massachusetts Financial Services
8
Massachusetts Financial Services
Massachusetts
$28.8M +$6.94M +288,268 +54%
Vanguard Group
9
Vanguard Group
Pennsylvania
$21.3M +$564K +23,439 +4%
BlackRock
10
BlackRock
New York
$12.3M +$758K +31,486 +10%
BG
11
Bellevue Group
Switzerland
$10M +$2.71M +112,426 +65%
TD Asset Management
12
TD Asset Management
Ontario, Canada
$6.44M +$3.67M +152,308 +480%
Citadel Advisors
13
Citadel Advisors
Florida
$6.4M +$1.12M +46,711 +34%
DCM
14
Driehaus Capital Management
Illinois
$6.3M +$4.33M +180,096 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$6M +$275K +11,446 +7%
DI
16
DUMAC Inc
North Carolina
$5.78M +$3.98M +165,179 New
RI
17
RTW Investments
New York
$5.64M -$794K -32,998 -17%
State Street
18
State Street
Massachusetts
$4M +$707K +29,364 +35%
SV
19
Sturgeon Ventures
United Kingdom
$2.35M -$101K -4,216 -6%
Northern Trust
20
Northern Trust
Illinois
$2.27M -$26.2K -1,089 -2%
Morgan Stanley
21
Morgan Stanley
New York
$2.22M +$595K +24,706 +64%
ACM
22
Atika Capital Management
New York
$2.03M +$1.4M +58,138 New
Manulife (Manufacturers Life Insurance)
23
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.95M +$1.35M +56,167 New
Brown Advisory
24
Brown Advisory
Maryland
$1.92M +$1.32M +54,824 New
Charles Schwab
25
Charles Schwab
California
$1.8M +$29K +1,206 +2%
1
2 3 4

PRCT Hedge Fund Activity: Q1 2022 in Review

58 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q1 2022, worth a combined $1.08B — up 48% from $732M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of PRCT and 19 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 18 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $58.8M. The largest seller was Viking Global Investors, cutting an estimated $30.1M.

  • 58 institutional investors held Procept Biorobotics (PRCT) as of Q1 2022, down from 60 in Q4 2021.
  • Funds reported $1.08B of Procept Biorobotics stock for Q1 2022, up 48% quarter-over-quarter.
  • 19 funds opened new Procept Biorobotics positions in Q1 2022 and 20 closed out, a net change of -1 holder.
  • The largest Procept Biorobotics buyer in Q1 2022 was T. Rowe Price Associates, an estimated $58.8M added.
  • The largest Procept Biorobotics seller in Q1 2022 was Viking Global Investors, an estimated $30.1M sold.

Based on aggregated 13F filings for Q1 2022.